The best way to purchase AKB-48

The best way to get legal high with us to buy AKB-48 for sale

APINACA (AKB48) is a drug that acts as a reasonably potent agonist for the cannabinoid receptors, with a Ki of 304.5nM and an EC50 of 585nM at CB1. It had never previously been reported in the scientific or patent literature.

APINACA (AKB48, N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide) is a drug that acts as a reasonably potent agonist for cannabinoid receptors. Although it had never previously been reported in the scientific literature, it was first identified as an ingredient in synthetic cannabis smoking blends. Its structure resembles compounds disclosed by the University of Connecticut patent (WO 2003/035005) but with a simple pentyl chain on the indazole 1-position.

APINACA (AKB48, N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide) is a drug that acts as a reasonably potent agonist for the cannabinoid receptors, with a Ki of 304.5nM and an EC50 of 585nM at CB1. It was first identified by laboratories in Japan in March 2012 as an ingredient in synthetic cannabis smoking blends, along with a related compound, APICA.

APINACA is a drug that acts as a reasonably potent agonist for the cannabinoid receptors, with a Ki of 304.5nM and an EC50 of 585nM at CB1. It was first identified by laboratories in Japan in March 2012 as an ingredient in synthetic cannabis smoking blends, along with a related compound, APICA.

A substance with the systematic name N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide is a powerful cannabinoid agonist sold online as a designer drug.

APINACA is a psychoactive drug first identified in March 2012 as an ingredient in synthetic cannabis smoking blends.

Looking for online research chemicals AKB-48 vendor USA

APINACA has a Ki of 304.5nM in a radioligand binding assay of human CB1 receptors.

APINACA (AKB48, N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide) is a noncompetitive antagonist of the CB1 receptor (Ki = 304.5 nM), inhibiting cannabinoid agonist binding in competition assays with full cannabinoid agonists such as WIN 55,212-2.

APINACA is a noncompetitive antagonist of the CB1 receptor (Ki = 304.5 nM) that inhibits agonist binding in competition assays of cannabinoid full agonists such as WIN 55,212-2.

APINACA is a noncompetitive cannabinoid receptor antagonist.

APINACA is one of the synthetic cannabinoids (SCBs) that has been controlled under the temporary banning law since 2012. APINACA is a non-selective CB1 receptor antagonist in the 'Black mamba' herbal smoking blend.

APINACA is a synthetic cannabinoid--one of the many compounds developed in recent years for use as psychoactive recreational drugs.

APINACA (AKB48, N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide) is a synthetic cannabinoid that acts as a reasonably potent agonist for the CB1 receptor.

APINACA is a drug that acts as a reasonably potent agonist for the cannabinoid receptors, with a Ki of 304.5nM and an EC50 of 585nM at CB1. It had never previously been reported in the scientific or patent literature and was first identified by laboratories in Japan in March 2012 as an ingredient in synthetic cannabis smoking blends.